Skip header and navigation

Refine By

9 records – page 1 of 1.

[Accelerated immunization with native staphylococcal anatoxin of pregnant women at a maternity hospital]

https://arctichealth.org/en/permalink/ahliterature57932
Source
Pediatr Akus Ginekol. 1978;(2):49-50
Publication Type
Article
Date
1978

[Allergic manifestations and the state of nonspecific immunity in children with disordered arterial pressure]

https://arctichealth.org/en/permalink/ahliterature43473
Source
Pediatr Akus Ginekol. 1973;6:19-21
Publication Type
Article
Date
1973

Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein.

https://arctichealth.org/en/permalink/ahliterature14132
Source
Clin Diagn Lab Immunol. 2000 Jan;7(1):14-20
Publication Type
Article
Date
Jan-2000
Author
P. Colque-Navarro
M. Palma
B. Söderquist
J I Flock
R. Möllby
Author Affiliation
Microbiology and Tumorbiology Center, Karolinska Institute, S-171 77 Stockholm, Sweden. patricia.colque@mtc.ki.se
Source
Clin Diagn Lab Immunol. 2000 Jan;7(1):14-20
Date
Jan-2000
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Antibodies - immunology
Antigens - immunology
Arthritis, Infectious - immunology
Bacterial Proteins - immunology
Carrier Proteins - immunology
Coagulase - immunology
Comparative Study
Endocarditis - immunology
Enzyme-Linked Immunosorbent Assay - methods
Humans
Middle Aged
Osteitis - immunology
Septicemia - immunology
Staphylococcal Infections - immunology
Staphylococcus aureus - immunology
Sweden
Abstract
We analyzed the serum antibody responses against two Staphylococcus aureus fibrinogen binding proteins, the cell-bound clumping factor (Clf) and an extracellular fibrinogen binding protein (Efb). The material consisted of 105 consecutive serum samples from 41 patients suffering from S. aureus septicemia and 72 serum samples from healthy individuals. An enzyme-linked immunosorbent assay (ELISA) was developed. Healthy individuals showed variable levels of antibodies against the studied antigens, and cutoff levels (upper 95th percentile) against these antigens were determined. No correlation was seen between serum antibody levels against Clf and Efb. In acute-phase samples 27% of patients showed positive antibody levels against Clf and 10% showed positive levels against Efb, while in convalescent-phase samples 63% (26 of 41) showed a positive serology against Clf and 49% (20 of 41) showed a positive serology against Efb. Antibody levels against Efb were significantly lower in the acute-phase sera than in sera from healthy individuals (P = 0. 002). An antibody response against Clf was most frequent in patients suffering from osteitis plus septic arthritis and from endocarditis (80% positive). The antibody response against Efb appeared to develop later in the course of disease. A possible biological effect of measured antibodies was demonstrated with the help of an inhibition ELISA, in which both high-titer and low-titer sera inhibited the binding of bacteria to fibrinogen. In conclusion, we have demonstrated in vivo production of S. aureus fibrinogen binding proteins during deep S. aureus infections and a possible diagnostic and prophylactic role of the corresponding serum antibodies in such infections.
PubMed ID
10618270 View in PubMed
Less detail

[Determination of IgM and IgG antitoxins in children with staphylococcal diseases using the passive hemagglutination reaction]

https://arctichealth.org/en/permalink/ahliterature41756
Source
Pediatr Akus Ginekol. 1978;(3):9-12
Publication Type
Article
Date
1978

[Examination of the bactericidal effect of amniotic fluid]

https://arctichealth.org/en/permalink/ahliterature66866
Source
Pediatr Akus Ginekol. 1967 Jan-Feb;1:57-8
Publication Type
Article

Immunotherapy against antibiotic-resistant bacteria: the Russian experience with an antistaphylococcal hyperimmune plasmaand immunoglobulin.

https://arctichealth.org/en/permalink/ahliterature197029
Source
Microbes Infect. 2000 Sep;2(11):1383-92
Publication Type
Article
Date
Sep-2000
Author
J. Kelly
Author Affiliation
Coates & Jarratt, Inc., 4455 Connecticut Avenue, A500, Washington, DC 20008, USA.
Source
Microbes Infect. 2000 Sep;2(11):1383-92
Date
Sep-2000
Language
English
Publication Type
Article
Keywords
Animals
Antitoxins - therapeutic use
Drug Resistance, Microbial
Humans
Immune Sera - administration & dosage
Immunization, Passive - adverse effects
Rabbits
Russia
Staphylococcal Infections - immunology - prevention & control - therapy
Staphylococcal Toxoid - immunology
Staphylococcus aureus - drug effects - immunology
Vaccination
Abstract
The Russian experience with the preparation and clinical application of an antitoxic antistaphylococcal hyperimmune plasma and immunoglobulin is described. The immunotherapies were developed in the late 1960s and put into widespread use in the Soviet Union for the prophylaxis and treatment of sepsis, pneumonia, and other conditions caused by an epidemic of antibiotic-resistant Staphylococcus aureus.
PubMed ID
11018455 View in PubMed
Less detail

[Microbiological and immuno-biochemical changes in children with staphylococcal destruction of the lungs]

https://arctichealth.org/en/permalink/ahliterature43866
Source
Pediatr Akus Ginekol. 1971 Jul-Aug;4:23-4
Publication Type
Article

[The correction of immunity in adolescents and children with focal staphylococcal diseases]

https://arctichealth.org/en/permalink/ahliterature34001
Source
Lik Sprava. 1997 Sep-Oct;(5):153-4
Publication Type
Article
Author
Iu V Marushko
Source
Lik Sprava. 1997 Sep-Oct;(5):153-4
Language
Ukrainian
Publication Type
Article
Keywords
Adolescent
Adsorption
Antibody Formation - drug effects - radiation effects
Child
Child, Preschool
Combined Modality Therapy
English Abstract
Female
Focal Infection - immunology - therapy
Humans
Immunity, Cellular - drug effects - radiation effects
Male
Microwaves - therapeutic use
Staphylococcal Infections - immunology - therapy
Staphylococcal Toxoid - therapeutic use
Abstract
The aim of the work done was to improve treatment options for focal Staphylococcus-induced diseases in adolescents and children with the aid of adsorbed staphylococcal anatoxin (ASA) concurrently with low-intensive EHF therapy. Overall fifty patients aged 3 to 17 years with Staphylococcus infection in tonsils, nose, ears were kept under medical surveillance. ASA and EHF therapies were instituted according to the developed schemes of such therapies. Positive dynamics was shown of clinical picture and parameters characterizing humoral and cell-mediated immunity. There were no unfavourable side-effects. The proposed mode of treatment can, we believe, be widely used in a clinical setting.
PubMed ID
9491728 View in PubMed
Less detail

9 records – page 1 of 1.